Christopher R. Concannon
Known title: President & COOCIK: 0001251713
Christopher R. Concannon's purchase track record
Christopher R. Concannon has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/14/2023 | MKTX | $1.02M | -6.2% | -4.0% | +11.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MKTX | ▼ Sell | Tax Withholding | 349 | $60K | 4/3/2026 | View on chart |
| MKTX | ▲ Buy | Grant | 6,588 | $0 | 2/15/2026 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 1,750 | $314K | 2/15/2026 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 866 | $155K | 2/15/2026 | View on chart |
| MKTX | ▲ Buy | Grant | 1,696 | $0 | 2/13/2026 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 693 | $134K | 2/15/2025 | View on chart |
| MKTX | ▲ Buy | Grant | 6,202 | $0 | 2/15/2025 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 585 | $127K | 1/31/2025 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 243 | $53K | 1/31/2025 | View on chart |
| MKTX | ▲ Buy | Grant | 1,622 | $0 | 1/29/2025 | View on chart |
| MKTX | ▲ Buy | Grant | 3,991 | $0 | 2/15/2024 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 195 | $53K | 1/31/2024 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 305 | $84K | 1/31/2024 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 459 | $126K | 1/31/2024 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 5,077 | $1.4M | 1/22/2024 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 4,042 | $1.1M | 1/22/2024 | View on chart |
| MKTX | ▲ Buy | Grant | 899 | $0 | 1/16/2024 | View on chart |
| MKTX | ▲ Buy | Open Market | 104 | $24K | 8/14/2023 | View on chart |
| MKTX | ▲ Buy | Open Market | 2,203 | $524K | 8/14/2023 | View on chart |
| MKTX | ▲ Buy | Open Market | 900 | $215K | 8/14/2023 | View on chart |
| MKTX | ▲ Buy | Open Market | 600 | $144K | 8/14/2023 | View on chart |
| MKTX | ▲ Buy | Open Market | 59 | $14K | 8/14/2023 | View on chart |
| MKTX | ▲ Buy | Open Market | 404 | $96K | 8/14/2023 | View on chart |
| MKTX | ▲ Buy | Grant | 2,729 | $0 | 4/3/2023 | View on chart |
| MKTX | ▲ Buy | Grant | 1,967 | $0 | 2/15/2023 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 1,528 | $556K | 1/31/2023 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 195 | $71K | 1/31/2023 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 313 | $114K | 1/31/2023 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 512 | $186K | 1/31/2023 | View on chart |
| MKTX | ▲ Buy | Grant | 2,993 | $0 | 1/18/2023 | View on chart |
| MKTX | ▲ Buy | Grant | 1,805 | $0 | 1/31/2022 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 511 | $176K | 1/31/2022 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 202 | $70K | 1/31/2022 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 3,931 | $1.4M | 1/22/2022 | View on chart |
| MKTX | ▼ Sell | Tax Withholding | 2,382 | $868K | 1/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
MarketAxess Reports Q2 Earnings and New Data Integration
MarketAxess released its Q2 earnings, showing the company’s performance in the fixed‑income market. The firm also announced that Arcesium will use more MarketAxess data and analytics to improve fixed‑income workflows, which could broaden its reach. Analysts note that while the stock is trading near the top of its 52‑week range, it is compared to BGC as a potential value play, and some analysts warn it could drop sharply in October.
MarketAxess Reports Q2 Earnings and New Data Integration. MarketAxess released its Q2 earnings, showing the company’s performance in the fixed‑income market. The firm also announced that Arcesium will use more MarketAxess data and analytics to improve fixed‑income workflows, which could broaden its reach. Analysts note that while the stock is trading near the top of its 52‑week range, it is compared to BGC as a potential value play, and some analysts warn it could drop sharply in October.